{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T01:45:34Z","timestamp":1767404734681,"version":"3.48.0"},"reference-count":45,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Clearway Global, LLC\u2014a wholly owned subsidiary of Sancilio & Company, Florida"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychoactive Drugs"],"DOI":"10.1080\/02791072.2025.2607726","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T01:43:22Z","timestamp":1767404602000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress"],"prefix":"10.1080","author":[{"given":"Frederick D.","family":"Sancilio","sequence":"first","affiliation":[{"name":"Florida Atlantic University","place":["Boca Raton, USA"]},{"name":"Lobe Sciences, Inc","place":["Vancouver, USA"]},{"name":"Clearway Global, LLC","place":["Stuart, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maghsoud","family":"Dariani","sequence":"additional","affiliation":[{"name":"Lobe Sciences, Inc","place":["Vancouver, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purvi","family":"Chavda","sequence":"additional","affiliation":[{"name":"Curexbio","place":["Ahmedabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsha Mysore","family":"Rajagopal","sequence":"additional","affiliation":[{"name":"Vipragen Biosciences Limited","place":["Mysore, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyl","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Clearway Global, LLC","place":["Stuart, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.70038"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow"},{"key":"e_1_3_6_5_1","doi-asserted-by":"crossref","unstructured":"Baumann S. R. Carhart-Harris D. Nutt D. Erritzoe and B. Szigeti. 2022. Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial. PsyArxiv preprint. https:\/\/europepmc.org\/article\/ppr\/ppr561082. (accessed October 19 2022).","DOI":"10.31234\/osf.io\/s4qhf"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0540-6"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-3008-z"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1333"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl8615"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7"},{"key":"e_1_3_6_11_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Hallucinogenic mushrooms drug profile. The European Monitoring Centre for Drugs and Drug Addiction. https:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/hallucinogenic-mushrooms_en. (accessed December 21 2024)."},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3006-z"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109686"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6865(97)00014-9"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115598338"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117415"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2022.0012"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00493"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.3c00123"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1359"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-024-06644-3"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(98)00067-X"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26102948"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109908"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v67n1110"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"issue":"10","key":"e_1_3_6_28_1","article-title":"Psilocybin: From ancient magic to modern medicine","volume":"73","author":"Nichols D. E.","year":"2020","unstructured":"Nichols, D. E. 2020. Psilocybin: From ancient magic to modern medicine. The Journal Of 73 (10).","journal-title":"The Journal Of"},{"key":"e_1_3_6_29_1","doi-asserted-by":"crossref","unstructured":"O\u2019Connor E. M. Henninger L. Perdue E. L. Coppola R. Thomas and B. N. Gaynes. 2023. Screening for depression anxiety and suicide risk in adults: a systematic evidence review for the US Preventive Services Task Force. 22-05295-EF-1. Rockville MD: Agency for Healthcare Research and Quality (US).","DOI":"10.1001\/jama.2023.7787"},{"key":"e_1_3_6_30_1","first-page":"204","article-title":"Comparative study of diazepam, mapratroline, fluvoxamine, trazodone and alprazolam in some animal models of depression","volume":"25","author":"Pal S. N.","year":"1993","unstructured":"Pal, S. N., and P. C. Dandiya. 1993. Comparative study of diazepam, mapratroline, fluvoxamine, trazodone and alprazolam in some animal models of depression. Indian Journal of Pharmacology 25:204\u201308.","journal-title":"Indian Journal of Pharmacology"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118791737"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104706"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds088"},{"issue":"7","key":"e_1_3_6_34_1","article-title":"The pharmacologic treatment of anxiety disorders: A review of progress","volume":"71","author":"Ravindran L. N.","year":"2010","unstructured":"Ravindran, L. N., and M. Stein. 2010. The pharmacologic treatment of anxiety disorders: A review of progress. The Journal of Clinical 71 (7).","journal-title":"The Journal of Clinical"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.09.012"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2008.10.037"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"issue":"2","key":"e_1_3_6_38_1","first-page":"57","article-title":"Pharmaceutical development considerations of psilocin and its prodrug psilocybin: A comprehensive review of published pharmacokinetic data","volume":"5","author":"Sancilio F.","year":"2024","unstructured":"Sancilio, F., M. Dariani, G. Singh, R. Sutariya, and P. Chavda. 2024. Pharmaceutical development considerations of psilocin and its prodrug psilocybin: A comprehensive review of published pharmacokinetic data. Journal of Clinical Pharmacology and Therapeutics 5 (2):57\u201363.","journal-title":"Journal of Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"e_1_3_6_39_1","first-page":"JCPT-05","article-title":"Phase 1, first-in-man clinical trial and pharmacokinetics of psilocin mucate (L-130)","volume":"5","author":"Sancilio F.","year":"2024","unstructured":"Sancilio, F., M. Madsen, M. Dariani, and G. Singh. 2024. Phase 1, first-in-man clinical trial and pharmacokinetics of psilocin mucate (L-130). Journal of Clinical Pharmacology and Therapeutics 5 (3):JCPT-05\u20131061.","journal-title":"Journal of Clinical Pharmacology and Therapeutics"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00962-y"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2021.06.008"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30030-7"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.12.006"},{"issue":"6633","key":"e_1_3_6_44_1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas M. V.","year":"2023","unstructured":"Vargas, M. V., L. E. Dunlap, C. Dong, S. J. Carter, R. J. Tombari, S. A. Jami, L. P. Cameron, S. D. Patel, J. J. Hennessey, H. N. Saeger et al, 2023. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science 379(6633):700\u2013706.","journal-title":"Science"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105899"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000431"}],"container-title":["Journal of Psychoactive Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2025.2607726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T01:43:24Z","timestamp":1767404604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02791072.2025.2607726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":45,"alternative-id":["10.1080\/02791072.2025.2607726"],"URL":"https:\/\/doi.org\/10.1080\/02791072.2025.2607726","relation":{},"ISSN":["0279-1072","2159-9777"],"issn-type":[{"value":"0279-1072","type":"print"},{"value":"2159-9777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}